Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 829 shares at $6.74 ($6K) on 2020-06-22, disclosed to the SEC on 2020-06-23.
Seasonal sale ($6k) by See Remarks — this insider has traded CLVS in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |